|
Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial |
journalArticle |
2018 |
Bahig, H.; Yuan, Y.; Mohamed, A. S. R.; Brock, K. K.; Ng, S. P.; Wang, J.; Ding, Y.; Hutcheson, K.; McCulloch, M.; Balter, P. A.; Lai, S. Y.; Al-Mamgani, A.; Sonke, J. J.; van der Heide, U. A.; Nutting, C.; Li, X. A.; Robbins, J.; Awan, M.; Karam, I.; Newbold, K.; Harrington, K.; Oelfke, U.; Bhide, S.; Philippens, M. E. P.; Terhaard, C. H. J.; McPartlin, A. J.; Blanchard, P.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Phan, J.; Cazoulat, G.; Aristophanous, M.; McSpadden, K. K.; Garcia, J. A.; van den Berg, C. A. T.; Raaijmakers, C. P. J.; Kerkmeijer, L.; Doornaert, P.; Blinde, S.; Frank, S. J.; Fuller, C. D. |
|
Phase I–II trial designs: how early should efficacy guide the dose recommendation process? |
journalArticle |
2018 |
Paoletti, X; Postel-Vinay, S |
|
Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT |
journalArticle |
2018 |
Mohamed, A. S. R.; Bahig, H.; Aristophanous, M.; Blanchard, P.; Kamal, M.; Ding, Y.; Cardenas, C. E.; Brock, K. K.; Lai, S. Y.; Hutcheson, K. A.; Phan, J.; Wang, J.; Ibbott, G.; Gabr, R. E.; Narayana, P. A.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Fuller, C. D.; Group, M. D. Anderson MRLinac Development Working |
|
surrosurv: An R package for the evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials |
journalArticle |
2018 |
Rotolo, F.; Paoletti, X.; Michiels, S. |
|
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial |
journalArticle |
2018 |
Tao, Y.; Auperin, A.; Sire, C.; Martin, L.; Khoury, C.; Maingon, P.; Bardet, E.; Kaminsky, M. C.; Lapeyre, M.; Chatellier, T.; Alfonsi, M.; Pointreau, Y.; Jadaud, E.; Géry, B.; Zawadi, A.; Tourani, J. M.; Laguerre, B.; Coutte, A.; Racadot, S.; Hasbini, A.; Malaurie, E.; Borel, C.; Meert, N.; Cornely, A.; Ollivier, N.; Casiraghi, O.; Sun, X. S.; Bourhis, J. |
|
[Data sources, the data used, and the modality for collection] |
journalArticle |
2018 |
Mercier, G.; Costa, N.; Dutot, C.; Riche, V. P. |
|
Image-guided tumour biopsies in a prospective molecular triage study (MOSCATO-01): What are the real risks? |
journalArticle |
2018 |
Prud''''homme, C.; Deschamps, F.; Allorant, A.; Massard, C.; Hollebecque, A.; Yevich, S.; Ngo-Camus, M.; Gravel, G.; Nicotra, C.; Michiels, S.; Scoazec, J. Y.; Lacroix, L.; Solary, E.; Soria, J. C.; De Baere, T.; Tselikas, L. |
|
How to Reliably Assess Nodal Status in Distal Pancreatectomy for Adenocarcinoma |
journalArticle |
2018 |
Faron, M.; Vuarnesson, H.; Boher, J. M.; Bachellier, P.; Sauvanet, A.; Sa Cunha, A.; Le Treut, Y. P.; Mabrut, J. Y.; Delpero, J. R.; Paye, F. |
|
Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting |
journalArticle |
2018 |
Imbimbo, M.; Maury, J. M.; Garassino, M.; Girard, N. |
|
Radiation-Related Alterations of Taste Function in Patients With Head and Neck Cancer: a Systematic Review |
journalArticle |
2018 |
Deshpande, T. S.; Blanchard, P.; Wang, L.; Foote, R. L.; Zhang, X.; Frank, S. J. |
|
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis |
journalArticle |
2018 |
Bidard, F. C.; Michiels, S.; Riethdorf, S.; Mueller, V.; Esserman, L. J.; Lucci, A.; Naume, B.; Horiguchi, J.; Gisbert-Criado, R.; Sleijfer, S.; Toi, M.; Garcia-Saenz, J. A.; Hartkopf, A.; Generali, D.; Rothé, F.; Smerage, J.; Muinelo-Romay, L.; Stebbing, J.; Viens, P.; Magbanua, M. J. M.; Hall, C. S.; Engebraaten, O.; Takata, D.; Vidal-Martínez, J.; Onstenk, W.; Fujisawa, N.; Diaz-Rubio, E.; Taran, F. A.; Cappelletti, M. R.; Ignatiadis, M.; Proudhon, C.; Wolf, D. M.; Bauldry, J. B.; Borgen, E.; Nagaoka, R.; Carañana, V.; Kraan, J.; Maestro, M.; Brucker, S. Y.; Weber, K.; Reyal, F.; Amara, D.; Karhade, M. G.; Mathiesen, R. R.; Tokiniwa, H.; Llombart-Cussac, A.; Meddis, A.; Blanche, P.; d''''Hollander, K.; Cottu, P.; Park, J. W.; Loibl, S.; Latouche, A.; Pierga, J. Y.; Pantel, K. |
|
Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes |
journalArticle |
2018 |
Frank, S. J.; Pugh, T. J.; Blanchard, P.; Mahmood, U.; Graber, W. J.; Kudchadker, R. J.; Davis, J. W.; Kim, J.; Choi, H.; Troncoso, P.; Kuban, D. A.; Choi, S.; McGuire, S.; Hoffman, K. E.; Chen, H. C.; Wang, X.; Swanson, D. A. |
|
ER+ breast cancers resistant to prolonged neoadjuvant letrozole exhibit an E2F4 transcriptional program sensitive to CDK4/6 inhibitors |
journalArticle |
2018 |
Guerrero-Zotano, A.; Stricker, T.; Formisano, L.; Hutchinson, K. E.; Stover, D. G.; Lee, K. M.; Schwarz, L. J.; Giltnane, J. M.; Estrada, M. V.; Jansen, V. M.; Servetto, A.; Gavilá, J.; Pérez-Fidalgo, J. A.; Lluch, A.; Llombart-Cussac, A.; Bayar, M. A.; Michiels, S.; Andre, F.; Arnedos, M.; Guillem, V.; Ruiz-Simon, A.; Arteaga, C. L. |
|
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial |
journalArticle |
2018 |
Schlumberger, M.; Leboulleux, S.; Catargi, B.; Deandreis, D.; Zerdoud, S.; Bardet, S.; Rusu, D.; Godbert, Y.; Buffet, C.; Schvartz, C.; Vera, P.; Morel, O.; Benisvy, D.; Bournaud, C.; Toubert, M. E.; Kelly, A.; Benhamou, E.; Borget, I. |
|
LONG-TERM SURVIVAL IN PATIENTS RESPONDING TO ANTI-PD-1/PD-L1 THERAPY AND DISEASE OUTCOME UPON TREATMENT DISCONTINUATION |
journalArticle |
2018 |
Gauci, M. L.; Lanoy, E.; Champiat, S.; Caramella, C.; Ammari, S.; Aspeslagh, S.; Varga, A.; Baldini, C.; Bahleda, R.; Gazzah, A.; Michot, J. M.; Postel-Vinay, S.; Angevin, E.; Ribrag, V.; Hollebecque, A.; Soria, J. C.; Robert, C.; Massard, C.; Marabelle, A. |
|
Daily Biopsy Diagnosis in Surgical Pathology: Concordance Between Light Microscopy and Whole-Slide Imaging in Real-Life Conditions |
journalArticle |
2018 |
Villa, I.; Mathieu, M. C.; Bosq, J.; Auperin, A.; Pomerol, J. F.; Lacroix-Triki, M.; Scoazec, J. Y.; Dartigues, P. |
|
Anemia and neutrophil-to-lymphocyte ratio are prognostic in p16-positive oropharyngeal carcinoma treated with concurrent chemoradiation |
journalArticle |
2018 |
Gorphe, P.; Chekkoury Idrissi, Y.; Tao, Y.; Schernberg, A.; Ou, D.; Temam, S.; Casiraghi, O.; Blanchard, P.; Mirghani, H. |
|
Scoring of tumor-infiltrating lymphocytes: From visual estimation to machine learning |
journalArticle |
2018 |
Klauschen, F.; Müller, K. R.; Binder, A.; Bockmayr, M.; Hägele, M.; Seegerer, P.; Wienert, S.; Pruneri, G.; de Maria, S.; Badve, S.; Michiels, S.; Nielsen, T. O.; Adams, S.; Savas, P.; Symmans, F.; Willis, S.; Gruosso, T.; Park, M.; Haibe-Kains, B.; Gallas, B.; Thompson, A. M.; Cree, I.; Sotiriou, C.; Solinas, C.; Preusser, M.; Hewitt, S. M.; Rimm, D.; Viale, G.; Loi, S.; Loibl, S.; Salgado, R.; Denkert, C. |
|
Tolerance and outcomes of stereotactic radiosurgery combined with anti-programmed cell death-1 (pembrolizumab) for melanoma brain metastases |
journalArticle |
2018 |
Nardin, C.; Mateus, C.; Texier, M.; Lanoy, E.; Hibat-Allah, S.; Ammari, S.; Robert, C.; Dhermain, F. |
|
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials |
journalArticle |
2018 |
Early Breast Cancer Trialists' Collaborative, Group |
|
Pharmacological modulation of radiation-induced oral mucosal complications |
journalArticle |
2018 |
Bockel, S.; Vallard, A.; Levy, A.; Francois, S.; Bourdis, M.; Le Gallic, C.; Riccobono, D.; Annede, P.; Drouet, M.; Tao, Y.; Blanchard, P.; Deutsch, E.; Magne, N.; Chargari, C. |
|
Prevalence of burnout, depression and job satisfaction among French senior and resident radiation oncologists |
journalArticle |
2018 |
Lazarescu, I.; Dubray, B.; Joulakian, M. B.; Blanchard, P.; Chauvet, B.; Mahe, M. A.; Mornex, F.; Rocher, F.; Thureau, S. |
|
Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors |
journalArticle |
2018 |
Bahleda, R.; Le Deley, M. C.; Bernard, A.; Chaturvedi, S.; Hanley, M.; Poterie, A.; Gazzah, A.; Varga, A.; Touat, M.; Deutsch, E.; Massard, C.; Van De Velde, H.; Hollebecque, A.; Sallansonnet-Froment, M.; Ricard, D.; Taillia, H.; Angevin, E.; Ribrag, V.; Soria, J. C. |
|
Influence of tumor-associated macrophages and HLA class I expression according to HPV status in head and neck cancer patients receiving chemo/bioradiotherapy |
journalArticle |
2018 |
Ou, D.; Adam, J.; Garberis, I.; Blanchard, P.; Nguyen, F.; Levy, A.; Casiraghi, O.; Gorphe, P.; Breuskin, I.; Janot, F.; Temam, S.; Scoazec, J. Y.; Deutsch, E.; Tao, Y. |
|
Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers |
journalArticle |
2018 |
Cabel, L.; Fuerea, A.; Lacroix, L.; Baldini, C.; Martin, P.; Hollebecque, A.; Postel-Vinay, S.; Varga, A.; Balheda, R.; Gazzah, A.; Michot, J. M.; Marabelle, A.; Rouleau, E.; Solary, E.; De Baere, T.; Angevin, E.; Armand, J. P.; Michiels, S.; Scoazec, J. Y.; Ammari, S.; André, F.; Soria, J. C.; Massard, C.; Verlingue, L. |
|
[Standard or specific unit costs: Which criteria for choosing an economic evaluation of health strategies in multicentric studies?] |
journalArticle |
2018 |
Margier, J.; Baffert, S.; Le Corroller-Soriano, A. G. |
|
[Editorial] |
journalArticle |
2018 |
Perrier, L. |
|
Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease |
journalArticle |
2018 |
Danlos, F. X.; Voisin, A. L.; Dyevre, V.; Michot, J. M.; Routier, E.; Taillade, L.; Champiat, S.; Aspeslagh, S.; Haroche, J.; Albiges, L.; Massard, C.; Girard, N.; Dalle, S.; Besse, B.; Laghouati, S.; Soria, J. C.; Mateus, C.; Robert, C.; Lanoy, E.; Marabelle, A.; Lambotte, O. |
|
Results of external beam radiotherapy for diffuse choroidal hemangiomas in Sturge-Weber syndrome |
journalArticle |
2018 |
Randon, M.; Lévy-Gabriel, C.; Abbas, R.; Dendale, R.; Lumbroso, L.; Desjardins, L.; Cassoux, N. |
|
Impact of missing individual patient data on 18 meta-analyses of randomised trials in oncology: Gustave Roussy experience |
journalArticle |
2018 |
Fayard, F.; Petit, C.; Lacas, B.; Pignon, J. P. |
|
Evaluation of Treatment Effect with Paired Failure Times in a Single-Arm Phase II Trial in Oncology |
journalArticle |
2018 |
Texier, M.; Rotolo, F.; Ducreux, M.; Bouché, O.; Pignon, J. P.; Michiels, S. |
|
Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates |
journalArticle |
2018 |
Espin, J.; Schlander, M.; Godman, B.; Anderson, P.; Mestre-Ferrandiz, J.; Borget, I.; Hutchings, A.; Flostrand, S.; Parnaby, A.; Jommi, C. |
|
All simulation models of breast cancer are wrong but some are useful |
journalArticle |
2018 |
Michiels, S.; Delaloge, S. |
|
LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer |
journalArticle |
2018 |
Seymour, L.; Le Teuff, G.; Brambilla, E.; Shepherd, F. A.; Soria, J. C.; Kratzke, R.; Graziano, S.; Douillard, J. Y.; Rosell, R.; Reiman, A.; Lacas, B.; Lueza, B.; Aviel-Ronen, S.; McLeer, A.; Le Chevalier, T.; Pirker, R.; Filipits, M.; Dunant, A.; Pignon, J. P.; Tsao, M. S.; Committee, L. ACE-Bio Steering |
|
Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines? |
journalArticle |
2018 |
Watson, S.; Menis, J.; Baldini, C.; Martin-Romano, P.; Michot, J. M.; Hollebecque, A.; Armand, J. P.; Massard, C.; Soria, J. C.; Postel-Vinay, S.; Paoletti, X. |
|
A proposal for a new PhD level curriculum on quantitative methods for drug development |
journalArticle |
2018 |
Jaki, T.; Gordon, A.; Forster, P.; Bijnens, L.; Bornkamp, B.; Brannath, W.; Fontana, R.; Gasparini, M.; Hampson, L. V.; Jacobs, T.; Jones, B.; Paoletti, X.; Posch, M.; Titman, A.; Vonk, R.; Koenig, F. |
|
Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer |
journalArticle |
2018 |
Devarakonda, S.; Rotolo, F.; Tsao, M. S.; Lanc, I.; Brambilla, E.; Masood, A.; Olaussen, K. A.; Fulton, R.; Sakashita, S.; McLeer-Florin, A.; Ding, K.; Le Teuff, G.; Shepherd, F. A.; Pignon, J. P.; Graziano, S. L.; Kratzke, R.; Soria, J. C.; Seymour, L.; Govindan, R.; Michiels, S. |
|
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort |
journalArticle |
2018 |
Blanchard, P.; Davis, J. W.; Frank, S. J.; Kim, J.; Pettaway, C. A.; Pugh, T. J.; Pisters, L. L.; Ward, J. F.; Choi, S.; Chapin, B. F.; Hoffman, K.; Navai, N.; Achim, M.; McGuire, S. E.; Matin, S. F.; Nguyen, Q.; Mahmood, U.; Graber, W. J.; Chen, H. C.; Wang, X.; Kuban, D. A. |
|
Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer |
journalArticle |
2018 |
Rotolo, F.; Zhu, C. Q.; Brambilla, E.; Graziano, S. L.; Olaussen, K.; Le-Chevalier, T.; Pignon, J. P.; Kratzke, R.; Soria, J. C.; Shepherd, F. A.; Seymour, L.; Michiels, S.; Tsao, M. S. |
|
A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02) |
journalArticle |
2018 |
Frikha, M.; Auperin, A.; Tao, Y.; Elloumi, F.; Toumi, N.; Blanchard, P.; Lang, P.; Sun, S.; Racadot, S.; Thariat, J.; Alfonsi, M.; Tuchais, C.; Cornely, A.; Moussa, A.; Guigay, J.; Daoud, J.; Bourhis, J.; Gortec |